Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549508 · ClinicalTrials.gov registry record · NA
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
A NA study, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT02549508: Completed NA study, sponsored by Fisher and Paykel Healthcare.
NCT02549508 is a NA study that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02549508, a NA study, has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this research is to examine the application of AutoCPAP with and without SensAwake in subjects with OSA and Post-Traumatic Stress Disorder (PTSD), and evaluate whether patients achieve better sleep quality and compliance with SensAwake, compared to the same treatment without SensAwake.
Primary Outcome
Hours per night averaged over total time period measured.
Interventions
- DEVICE AutoCPAP with SensAwake On
- DEVICE AutoCPAP with SensAwake Off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02549508 record still lists
NCT02549508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which AutoCPAP with SensAwake On is the first listed.
NCT02549508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02549508 about?
NCT02549508 is a clinical study titled "Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD". The purpose of this research is to examine the application of AutoCPAP with and without SensAwake in subjects with OSA and Post-Traumatic Stress Disorder (PTSD), and evaluate whether patients achieve better sleep quality and compliance with SensAwake, compared to the same treatment without SensAwake...
What is the current status of trial NCT02549508?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2015-10. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02549508?
The interventions under investigation include: AutoCPAP with SensAwake On (DEVICE), AutoCPAP with SensAwake Off (DEVICE).
Who is sponsoring clinical trial NCT02549508?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02549508's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia